Skip to content
Inciteful Med

Building Your Care Team & First Visit Prep

Last updated:

Managing Myasthenia Gravis effectively requires a multidisciplinary care team led by a neuromuscular specialist. Because symptoms fluctuate throughout the day, patients should bring a symptom journal, the MG-ADL scale, and visual evidence like photos of droopy eyelids to their appointments.

Key Takeaways

  • • A neuromuscular specialist should act as the quarterback of your Myasthenia Gravis care team.
  • • Because symptoms fluctuate, bring photos or videos of your symptoms at their worst to your medical appointments.
  • • Your care may require a multidisciplinary team, including a pulmonologist, neuro-ophthalmologist, and speech-language pathologist.
  • • Tracking your daily symptoms using a journal and the MG-ADL scale helps your doctor make an accurate assessment.
  • • Specialized, high-volume neuromuscular centers often provide better outcomes and access to modern biologic therapies.

Because Myasthenia Gravis (MG) is a rare and complex condition, your success in managing it often depends on the team you build around you. While a general neurologist can diagnose MG, a neuromuscular specialist—a doctor who has completed extra training specifically in diseases of the nerves and muscles—is often better equipped to handle the nuances of the disease and provide access to the latest treatments [1][2][3].

Building Your Multidisciplinary Team

MG can affect many different parts of your body, meaning your care may require a team of specialists working together [1][2].

  • Neuromuscular Specialist: The “quarterback” of your team who oversees your overall treatment plan and medication management [1][4].
  • Thoracic Surgeon: A surgeon who specializes in the chest. They are essential if you require a thymectomy (removal of the thymus gland) [5][6][3].
  • Neuro-ophthalmologist: A specialist who focuses on vision issues related to the nervous system. They are critical for managing severe double vision or droopy eyelids and distinguishing MG from other eye-related conditions [7][8].
  • Pulmonologist: A lung specialist who monitors your respiratory muscle strength to help prevent or manage a myasthenic crisis [9][10].
  • Speech-Language Pathologist (SLP): A specialist who helps manage bulbar symptoms, such as difficulty swallowing (dysphagia) or speaking, to reduce the risk of choking or aspiration [11][12].

Preparing for Your First Visit

Because MG symptoms are often fatigable—meaning they fluctuate and may improve with rest—you might look and feel perfectly normal by the time you reach the doctor’s office [13][2]. Bringing clear evidence of your symptoms is the best way to help your specialist make an accurate assessment.

What to Bring:

  1. Visual Evidence: Take photos or short videos of your symptoms when they are at their worst. Gaze photographs—photos of your eyes while looking in different directions—can be more sensitive than some laboratory tests in identifying Ocular MG [14].
  2. Symptom Journal: Record your symptoms for a few days, paying close attention to the diurnal variation (how symptoms change throughout the day). Note if your weakness is worse in the evening or after specific activities [2][15].
  3. Functional Scores: Familiarize yourself with the MG-ADL (Activities of Daily Living) scale. Recording how symptoms like chewing or brushing your hair affect you daily provides a vital baseline for your doctor [16][17].
  4. Medical Records: Bring hard copies of all previous antibody tests, EMG reports, and chest CT or MRI scans to avoid redundant testing [18][19].

Seeking Specialized Care

Research indicates that management in specialized, high-volume centers leads to better clinical outcomes and a higher quality of life [1][9][20]. These centers are often more comfortable using modern therapies, such as FcRn antagonists or complement inhibitors, and are better at identifying atypical presentations that a general clinic might miss [21][22][20]. Choosing an expert team ensures that your treatment is proactive, rather than just reactive. Next, learn how to navigate daily life and mitigate risks in Survivorship & Daily Management.

Frequently Asked Questions

What type of doctor treats Myasthenia Gravis?
While a general neurologist can diagnose the condition, a neuromuscular specialist is best equipped to oversee your overall treatment plan. These specialists have extra training in nerve and muscle diseases and can provide access to the latest therapies.
Why should I take photos of my Myasthenia Gravis symptoms?
Because symptoms like droopy eyelids or double vision often fluctuate and improve with rest, you might look perfectly fine by the time you reach the doctor's office. Taking photos or videos when your symptoms are at their worst gives your specialist clear evidence to make an accurate assessment.
Which specialists should be on my Myasthenia Gravis care team?
Depending on your specific symptoms, your team might include a thoracic surgeon for a thymectomy, a neuro-ophthalmologist for vision issues, a pulmonologist to monitor respiratory strength, and a speech-language pathologist to help with swallowing and speaking difficulties.
What is the MG-ADL scale?
The MG-ADL (Activities of Daily Living) scale is a tool that tracks how symptoms impact your daily life, such as chewing, breathing, or brushing your hair. Familiarizing yourself with this scale helps provide a vital baseline for your doctor to measure your progress.
Why should I seek care at a specialized Myasthenia Gravis center?
Research shows that high-volume specialized centers generally lead to better clinical outcomes and a higher quality of life. These centers are often more experienced with modern targeted therapies and better at identifying unusual symptoms.

Questions for Your Doctor

  • • How many patients with Myasthenia Gravis (MG) do you currently manage in your practice?
  • • Do you have experience prescribing the newer targeted biologic therapies, such as FcRn antagonists or complement inhibitors?
  • • Which other specialists (like thoracic surgeons or speech therapists) do you typically collaborate with for MG care?
  • • Is your clinic part of a 'high-volume' center or a neuromuscular specialty group?
  • • What is the best way to reach your team if I notice my symptoms are worsening between appointments?

Questions for You

  • • Do your symptoms, like a droopy eye or slurred speech, seem to get worse as the day goes on or after physical activity?
  • • Have you taken photos or videos of your symptoms (like a droopy eyelid) when they are at their worst?
  • • Which symptom is having the biggest impact on your daily life right now—is it vision, mobility, or swallowing?
  • • Do you have copies of your previous blood tests, EMG results, and chest scans ready to share with a new specialist?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Recent advances in understanding and managing myasthenia gravis.

    Jordan A, Freimer M

    F1000Research 2018; (7()) doi:10.12688/f1000research.15973.1.

    PMID: 30443340
  2. 2

    Myasthenia Gravis and its Association With Thyroid Diseases.

    Amin S, Aung M, Gandhi FR, et al.

    Cureus 2020; (12(9)):e10248 doi:10.7759/cureus.10248.

    PMID: 33042687
  3. 3

    Infectious Thoracoabdominal Aortic Aneurysm Repair in a Patient with Myasthenia Gravis: A Case Report.

    Chiba K, Kinebuchi S, Komagamine M, et al.

    Annals of vascular diseases 2024; (17(4)):429-432 doi:10.3400/avd.cr.24-00099.

    PMID: 39726540
  4. 4

    Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report.

    Ohara H, Kikutsuji N, Iguchi N, Kinoshita M

    BMC neurology 2024; (24(1)):292 doi:10.1186/s12883-024-03804-y.

    PMID: 39174898
  5. 5

    Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.

    Zhu K, Li J, Huang X, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017; (38(10)):1753-1760 doi:10.1007/s10072-017-3058-7.

    PMID: 28707128
  6. 6

    Treatment of Ocular Myasthenia Gravis.

    Cornblath WT

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; (7(4)):257-259 doi:10.22608/APO.2018301.

    PMID: 30044061
  7. 7

    Ocular myasthenia gravis: a review and practical guide for clinicians.

    Shuey NH

    Clinical & experimental optometry 2022; (105(2)):205-213 doi:10.1080/08164622.2022.2029683.

    PMID: 35157811
  8. 8

    Pseudopartial Third Nerve Palsy as the Presenting Sign of Ocular Myasthenia Gravis.

    Bertolet AN, Druckenbrod RC

    Optometry and vision science : official publication of the American Academy of Optometry 2020; (97(5)):377-382 doi:10.1097/OPX.0000000000001512.

    PMID: 32413010
  9. 9

    Case Report: A myasthenia gravis patient complicated with renal failure was effectively treated with efgartigimod.

    Ke J, Zhao Q, Wang N, et al.

    Frontiers in immunology 2025; (16()):1526975 doi:10.3389/fimmu.2025.1526975.

    PMID: 40213565
  10. 10

    Diplopia in a patient presenting with "blurred vision": a case report.

    Harrison A, Mudhar O, Yoo J, Rampal M

    Journal of medical case reports 2023; (17(1)):402 doi:10.1186/s13256-023-04089-4.

    PMID: 37679826
  11. 11

    Myasthenia gravis with achalasia secondary to thymoma: a case report and literature review.

    Haridy NA, Khedr EM, Hasan AM, et al.

    The Egyptian journal of neurology, psychiatry and neurosurgery 2023; (59(1)):34 doi:10.1186/s41983-023-00636-4.

    PMID: 36936607
  12. 12

    Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.

    Scangarello FA, Angel-Buitrago L, Lang-Orsini M, et al.

    Clinical rheumatology 2021; (40(9)):3841-3851 doi:10.1007/s10067-021-05619-5.

    PMID: 33629204
  13. 13

    Diagnosis of Myasthenia Gravis.

    Rousseff RT

    Journal of clinical medicine 2021; (10(8)) doi:10.3390/jcm10081736.

    PMID: 33923771
  14. 14

    Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.

    Ahn J, Park KS, Kim JS, Hwang JM

    Journal of clinical neurology (Seoul, Korea) 2018; (14(3)):333-338 doi:10.3988/jcn.2018.14.3.333.

    PMID: 29856158
  15. 15

    Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG.

    Dewilde S, Philips G, Paci S, et al.

    BMJ open 2023; (13(1)):e066445 doi:10.1136/bmjopen-2022-066445.

    PMID: 36720569
  16. 16

    Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets.

    Janssen MF, Dewilde S, Wolfe GI, et al.

    Journal of the neurological sciences 2024; (463()):123135 doi:10.1016/j.jns.2024.123135.

    PMID: 39068745
  17. 17

    The Myasthenia Gravis-specific Activities of Daily Living scale as a useful outcome measure and in routine clinical management in Polish patients.

    Rozmilowska IM, Adamczyk-Sowa MH, Czyzewski D

    Neurologia i neurochirurgia polska 2018; (52(3)):368-373 doi:10.1016/j.pjnns.2017.12.012.

    PMID: 29370887
  18. 18

    Myasthenia gravis.

    Pasnoor M, Wolfe GI, Barohn RJ

    Handbook of clinical neurology 2024; (203()):185-203 doi:10.1016/B978-0-323-90820-7.00006-9.

    PMID: 39174248
  19. 19

    Atypical Seropositive Striated Muscle Antibody Myasthenia Gravis Presentation With Metastatic B1 Thymoma: A Rare Case.

    Randhawa JS, Kim LS, Aguilar C, et al.

    Cureus 2023; (15(2)):e35221 doi:10.7759/cureus.35221.

    PMID: 36968847
  20. 20

    Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

    Lin J, Chang T, Xiao L, et al.

    Journal of neurology 2026; (273(2)):146 doi:10.1007/s00415-026-13695-3.

    PMID: 41699286
  21. 21

    A Diagnostic Dilemma of Dysphonia: A Case Report on Laryngeal Myasthenia Gravis.

    Khan AA, Khan MW, Kundi TA, et al.

    Cureus 2021; (13(8)):e16878 doi:10.7759/cureus.16878.

    PMID: 34513453
  22. 22

    Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.

    Hoffmann S, Waters P, Jacobson L, et al.

    Neuromuscular disorders : NMD 2023; (33(2)):139-144 doi:10.1016/j.nmd.2023.01.002.

    PMID: 36746691

This page provides educational information on building a care team and preparing for medical appointments for Myasthenia Gravis. It does not replace professional medical advice from your neurologist or healthcare provider.

Stay up to date

Get notified when new research about Myasthenia gravis is published.

No spam. Unsubscribe anytime.